Compare STOK & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | PAYO |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | 2540 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2019 | N/A |
| Metric | STOK | PAYO |
|---|---|---|
| Price | $31.15 | $5.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | ★ $39.20 | $7.69 |
| AVG Volume (30 Days) | 478.9K | ★ 3.7M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.73 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $184,420,000.00 | N/A |
| Revenue This Year | N/A | $7.15 |
| Revenue Next Year | $77.49 | $10.28 |
| P/E Ratio | ★ N/A | $30.36 |
| Revenue Growth | ★ 404.50 | N/A |
| 52 Week Low | $9.36 | $4.08 |
| 52 Week High | $40.22 | $7.67 |
| Indicator | STOK | PAYO |
|---|---|---|
| Relative Strength Index (RSI) | 46.40 | 52.76 |
| Support Level | $30.34 | $4.82 |
| Resistance Level | $35.11 | $5.07 |
| Average True Range (ATR) | 1.54 | 0.19 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 51.03 | 67.11 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.